These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 33486489)

  • 1. SARS-CoV-2-Associated T-Cell Responses in the Presence of Humoral Immunodeficiency.
    Gupta S; Su H; Narsai T; Agrawal S
    Int Arch Allergy Immunol; 2021; 182(3):195-209. PubMed ID: 33486489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune Response to SARS-CoV-2 Vaccine in 2 Men.
    Gupta S; Su H; Agrawal S
    Int Arch Allergy Immunol; 2022; 183(3):350-359. PubMed ID: 34794147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptive Cellular Responses following SARS-CoV-2 Vaccination in Primary Antibody Deficiency Patients.
    Gupta S; Su H; Agrawal S; Demirdag Y; Tran M; Gollapudi S
    Pathogens; 2024 Jun; 13(6):. PubMed ID: 38921811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-Specific CD4
    Sauerwein KMT; Geier CB; Stemberger RF; Akyaman H; Illes P; Fischer MB; Eibl MM; Walter JE; Wolf HM
    Front Immunol; 2022; 13():827048. PubMed ID: 35237272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Immune Response to SARS-CoV-2 Vaccination: Insights Learned From Adult Patients With Common Variable Immune Deficiency.
    Quinti I; Locatelli F; Carsetti R
    Front Immunol; 2021; 12():815404. PubMed ID: 35126372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunophenotypic and functional analysis of lymphocyte subsets in common variable immunodeficiency patients without monogenic defects.
    Tofighi Zavareh F; Mirshafiey A; Yazdani R; Keshtkar AA; Abolhassani H; Mahdaviani SA; Habibi S; Sohani M; Rezaei N; Aghamohammadi A
    Scand J Immunol; 2022 Jul; 96(1):e13164. PubMed ID: 35305035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ICOS agonist vopratelimab modulates follicular helper T cells and improves B cell function in common variable immunodeficiency.
    Sepahi A; Ho HE; Vyas P; Umiker B; Kis-Toth K; Wiederschain D; Radigan L; Cunningham-Rundles C
    Clin Immunol; 2024 Jul; 264():110217. PubMed ID: 38621471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections.
    Bateman EA; Ayers L; Sadler R; Lucas M; Roberts C; Woods A; Packwood K; Burden J; Harrison D; Kaenzig N; Lee M; Chapel HM; Ferry BL
    Clin Exp Immunol; 2012 Nov; 170(2):202-11. PubMed ID: 23039891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable Abnormalities in T and B Cell Subsets in Ataxia Telangiectasia.
    Moeini Shad T; Yousefi B; Amirifar P; Delavari S; Rae W; Kokhaei P; Abolhassani H; Aghamohammadi A; Yazdani R
    J Clin Immunol; 2021 Jan; 41(1):76-88. PubMed ID: 33052516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic Analysis of CD4+ Treg, CD8+ Treg, and Breg Cells in Adult Common Variable Immunodeficiency Patients.
    Yesillik S; Agrawal S; Gollapudi SV; Gupta S
    Int Arch Allergy Immunol; 2019; 180(2):150-158. PubMed ID: 31284281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predominantly Antibody-Deficient Patients With Non-infectious Complications Have Reduced Naive B, Treg, Th17, and Tfh17 Cells.
    Edwards ESJ; Bosco JJ; Aui PM; Stirling RG; Cameron PU; Chatelier J; Hore-Lacy F; O'Hehir RE; van Zelm MC
    Front Immunol; 2019; 10():2593. PubMed ID: 31803177
    [No Abstract]   [Full Text] [Related]  

  • 12. Circulating Helper T-Cell Subsets and Regulatory T Cells in Patients With Common Variable Immunodeficiency Without Known Monogenic Disease.
    Azizi G; Mirshafiey A; Abolhassani H; Yazdani R; Jafarnezhad-Ansariha F; Shaghaghi M; Mortazavi-Jahromi SS; Noorbakhsh F; Rezaei N; Aghamohammadi A
    J Investig Allergol Clin Immunol; 2018; 28(3):172-181. PubMed ID: 29345621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients.
    Notarbartolo S; Ranzani V; Bandera A; Gruarin P; Bevilacqua V; Putignano AR; Gobbini A; Galeota E; Manara C; Bombaci M; Pesce E; Zagato E; Favalli A; Sarnicola ML; Curti S; Crosti M; Martinovic M; Fabbris T; Marini F; Donnici L; Lorenzo M; Mancino M; Ungaro R; Lombardi A; Mangioni D; Muscatello A; Aliberti S; Blasi F; De Feo T; Prati D; Manganaro L; Granucci F; Lanzavecchia A; De Francesco R; Gori A; Grifantini R; Abrignani S
    Sci Immunol; 2021 Aug; 6(62):. PubMed ID: 34376481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of Anti-SARS-CoV-2 Vaccines in Common Variable Immunodeficiency.
    Arroyo-Sánchez D; Cabrera-Marante O; Laguna-Goya R; Almendro-Vázquez P; Carretero O; Gil-Etayo FJ; Suàrez-Fernández P; Pérez-Romero P; Rodríguez de Frías E; Serrano A; Allende LM; Pleguezuelo D; Paz-Artal E
    J Clin Immunol; 2022 Feb; 42(2):240-252. PubMed ID: 34787773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study on the characteristics of circulating T follicular helper cells in liver transplant recipients.
    Zhang K; Sun YL; Yang F; Shi YC; Jin L; Liu ZW; Wang FS; Shi M
    Transpl Immunol; 2018 Apr; 47():32-36. PubMed ID: 29360498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG4-Related Disease (IgG4-RD) with Unique Combined Generalized Skin Rashes and Biliary Tract Manifestation: A Comprehensive Immunological Analysis.
    Jung Y; Agrawal S; Wang B; Gupta S
    Dermatopathology (Basel); 2024 Jul; 11(3):218-229. PubMed ID: 39051325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-lymphocyte subpopulations in patients with selective IgA deficiency.
    Nechvatalova J; Pikulova Z; Stikarovska D; Pesak S; Vlkova M; Litzman J
    J Clin Immunol; 2012 Jun; 32(3):441-8. PubMed ID: 22328142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific Antibody and the T-Cell Response Elicited by BNT162b2 Boosting After Two ChAdOx1 nCoV-19 in Common Variable Immunodeficiency.
    Goda V; Kriván G; Kulcsár A; Gönczi M; Tasnády S; Matula Z; Nagy G; Bekő G; Horváth M; Uher F; Szekanecz Z; Vályi-Nagy I
    Front Immunol; 2022; 13():907125. PubMed ID: 35784359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotypic profile of T cells in common variable immunodeficiency: is there an association with different clinical findings?
    Lanio N; Sarmiento E; Gallego A; Carbone J
    Allergol Immunopathol (Madr); 2009; 37(1):14-20. PubMed ID: 19268056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of various classifications for patients with common variable immunodeficiency (CVID) using measurement of B-cell subsets.
    Yazdani R; Seify R; Ganjalikhani-Hakemi M; Abolhassani H; Eskandari N; Golsaz-Shirazi F; Ansaripour B; Salehi E; Azizi G; Rezaei N; Aghamohammadi A
    Allergol Immunopathol (Madr); 2017; 45(2):183-192. PubMed ID: 27717724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.